Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Chapman

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Bioorganic & Medicinal Chemistry Letters|July 30, 2011
Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPARγ partial agonistMairi Sime, Amanda C Allan, Paul Chapman, et al.
Journal for Immunotherapy of Cancer|January 25, 2022
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analysesClaire F Friedman, Christine Spencer, Christopher R Cabanski, et al.
Nature Communications|April 1, 2026
Accelerated drug development using a digital formulator and a self-driving tableting data factoryFaisal Abbas, Mohammad Salehian, Peter Hou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2019
Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 MutationsMarjorie G Zauderer, Gowtham Jayakumaran, Mariel DuBoff, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 2, 2017
Patient perspectives on ipilimumab across the melanoma treatment trajectoryElyse Shuk, Alexander N Shoushtari, Jason Luke, et al.
BMJ Neurology Open|September 26, 2025
Integrated UPper limb and Language Impairment and Functional Training (UPLIFT) after stroke: study protocol for an umbrella Bayesian Optimal Phase IIa clinical trialKathryn S Hayward, Geoffrey Donnan, Erin Godecke, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Genetic dysregulation of an endothelial Ras signaling network in vein of Galen malformationsShujuan Zhao, Kedous Y Mekbib, Martijn A van der Ent, et al.
Nature Communications|November 17, 2023
Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformationsShujuan Zhao, Kedous Y Mekbib, Martijn A van der Ent, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Bioorganic & Medicinal Chemistry Letters|July 30, 2011
Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPARγ partial agonistMairi Sime, Amanda C Allan, Paul Chapman, et al.
Journal for Immunotherapy of Cancer|January 25, 2022
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analysesClaire F Friedman, Christine Spencer, Christopher R Cabanski, et al.
Nature Communications|April 1, 2026
Accelerated drug development using a digital formulator and a self-driving tableting data factoryFaisal Abbas, Mohammad Salehian, Peter Hou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2019
Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 MutationsMarjorie G Zauderer, Gowtham Jayakumaran, Mariel DuBoff, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 2, 2017
Patient perspectives on ipilimumab across the melanoma treatment trajectoryElyse Shuk, Alexander N Shoushtari, Jason Luke, et al.
BMJ Neurology Open|September 26, 2025
Integrated UPper limb and Language Impairment and Functional Training (UPLIFT) after stroke: study protocol for an umbrella Bayesian Optimal Phase IIa clinical trialKathryn S Hayward, Geoffrey Donnan, Erin Godecke, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Genetic dysregulation of an endothelial Ras signaling network in vein of Galen malformationsShujuan Zhao, Kedous Y Mekbib, Martijn A van der Ent, et al.
Nature Communications|November 17, 2023
Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformationsShujuan Zhao, Kedous Y Mekbib, Martijn A van der Ent, et al.
Pageof 6